Zhou B, Li J, Wu S, Zhang H, Luo Y, Chen J
Sci Rep. 2025; 15(1):8869.
PMID: 40087331
DOI: 10.1038/s41598-025-93029-x.
Matevish L, Guo J, Shubin A, MacConmara M, Hwang C, Raschzok N
Transplant Direct. 2025; 11(4):e1777.
PMID: 40078822
PMC: 11896107.
DOI: 10.1097/TXD.0000000000001777.
Xiao T, Chen D, Peng L, Li Z, Pan W, Dong Y
J Clin Transl Hepatol. 2025; 13(3):216-232.
PMID: 40078203
PMC: 11894393.
DOI: 10.14218/JCTH.2024.00375.
Tang Y, Hu H, Chen S, Hao B, Xu X, Zhu H
Sci Rep. 2025; 15(1):8591.
PMID: 40074806
PMC: 11903666.
DOI: 10.1038/s41598-025-92700-7.
Bu J, Li Z, Hu D, Lan L, Huang J, Wang X
Front Oncol. 2025; 15:1554711.
PMID: 40071095
PMC: 11893395.
DOI: 10.3389/fonc.2025.1554711.
SLC7A11, a disulfidptosis-related gene, correlates with multi-omics prognostic analysis in hepatocellular carcinoma.
Li S, Wang X, Xiao J, Yi J
Eur J Med Res. 2025; 30(1):161.
PMID: 40069889
PMC: 11900568.
DOI: 10.1186/s40001-025-02411-y.
RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma.
Zhu J, Wang L, Nie X, Ou S, Shen J, Zhang S
Oncogene. 2025; .
PMID: 40069332
DOI: 10.1038/s41388-025-03335-x.
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer.
Liu Y, Jiang W, Li X, Zhao H, Wang S
J Hepatocell Carcinoma. 2025; 12:513-526.
PMID: 40065840
PMC: 11892369.
DOI: 10.2147/JHC.S499966.
Serum-biomarker-based population screening model for hepatocellular carcinoma.
Liao W, Lin W, He Z, Feng C, Liu Y, Wang Z
iScience. 2025; 28(3):111981.
PMID: 40060905
PMC: 11889663.
DOI: 10.1016/j.isci.2025.111981.
The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.
Lin H, Jeon A, Chen K, Lee C, Wu L, Chong S
Br J Cancer. 2025; .
PMID: 40057667
DOI: 10.1038/s41416-025-02969-8.
Liver resection in patients with a history of local ablation for hepatocellular carcinoma has the risk of poor survival and serosal invasion.
Nishi Y, Sakamoto K, Uraoka M, Nagaoka T, Honjo M, Tamura K
Ann Gastroenterol Surg. 2025; 9(2):347-358.
PMID: 40046521
PMC: 11877331.
DOI: 10.1002/ags3.12872.
The LncRNA lnc-POTEM-4:14 promotes HCC progression by interacting with FOXK1.
Peng B, Quan Z, Liang L, Liu M, Hu K, Chen S
Sci Rep. 2025; 15(1):7672.
PMID: 40044876
PMC: 11882843.
DOI: 10.1038/s41598-025-92614-4.
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma.
Tang M, Xu Y, Pan M
J Hepatocell Carcinoma. 2025; 12:427-444.
PMID: 40040881
PMC: 11878290.
DOI: 10.2147/JHC.S509749.
Dysregulation of the SREBP pathway is associated with poor prognosis and serves as a potential biomarker for the diagnosis of hepatocellular carcinoma.
Li X, Wang Y, Liu J, Gao T, Cao L, Yan M
Mol Med Rep. 2025; 31(5).
PMID: 40017126
PMC: 11894594.
DOI: 10.3892/mmr.2025.13477.
Cellular Membrane Protein GRINA is Highly Expressed and Associated with Survival Outcomes in Liver Cancer Patients.
Song J, Guo S, Gao W, Yang Z, Tian Z
Curr Med Sci. 2025; 45(1):122-136.
PMID: 40011365
DOI: 10.1007/s11596-025-00025-3.
Mint3 as a Molecular Target Activated in the Early Stage of Hepatocarcinogenesis.
Nishitani M, Okada H, Nio K, Hayashi T, Terashima T, Iida N
Int J Mol Sci. 2025; 26(4).
PMID: 40003897
PMC: 11855386.
DOI: 10.3390/ijms26041430.
Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma.
Liu M, Li L, Cao L, Li W, Gu X, Yang M
J Immunother Cancer. 2025; 13(2).
PMID: 39988347
PMC: 11848677.
DOI: 10.1136/jitc-2024-010947.
Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.
Xie X, Tsui Y, Zhang V, Yu T, Husain A, Chiu Y
Cell Death Dis. 2025; 16(1):123.
PMID: 39984455
PMC: 11845619.
DOI: 10.1038/s41419-025-07451-0.
CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis.
Delgado M, Naranjo-Suarez S, Ramirez-Pedraza M, Cardenas B, Gallardo-Martinez C, Balvey A
JHEP Rep. 2025; 7(3):101296.
PMID: 39980747
PMC: 11840500.
DOI: 10.1016/j.jhepr.2024.101296.
Mitochondrial alterations and signatures in hepatocellular carcinoma.
Chen T, Lin S, Lee M, Wang H, Tsai K, Chou C
Cancer Metastasis Rev. 2025; 44(1):34.
PMID: 39966277
PMC: 11836208.
DOI: 10.1007/s10555-025-10251-9.
